2005Shanxi Clinical MedicineRequires access

Efficacy of glutathione in the treatment of viral hepatitis

Mingxi Bao

Open publisher page 0 citations

Abstract

Objective:To observe the efficacy and safety of glutathione in the treatment of viral hepatitis.Methods:In the series,106 patients with viral hepatitis were randomly divided into groups A and B.Patients in group A received glutathione for four weeks,patient in group B received potassium magnesium aspartate for four weeks.Results:In Group A,at the end of treatment,the effective rate for tired and anorexia in patients with actue hepatitis were94.4% and 88.9%,respectively,in patients with chronic hepatitis were 88.7%,85.7%,which were significantly higher than that in group B(P0.05).STB,SCB,TBA,ALT and AST were lower in group A than in group B(P0.05).The increase of albumin after treatment was more significant in group A than in group B(P0.05).Conclusion:Glutathione has better efficacy than potassium magnesium aspartate in the treatment of patients with viral hepatitis.

About this research paper

What this paper is about

Objective:To observe the efficacy and safety of glutathione in the treatment of viral hepatitis.Methods:In the series,106 patients with viral hepatitis were randomly divided into groups A and B.Patients in group A received glutathione for four weeks,patient in group B received potassium magnesium aspartate for four weeks.Results:In Group A,at the end of treatment,the effective rate for tired and anorexia in patients with actue hepatitis were94.4% and 88.9%,respectively,in patients with chronic hepatitis were 88.7%,85.7%,which were significantly higher than that in group B(P0.05).STB,SCB,TBA,ALT and AST were lower in group A than in group B(P0.05).The increase of albumin after treatment was more significant in group A than in group B(P0.05).Conclusion:Glutathione has better efficacy than potassium magnesium aspartate in the treatment of patients with viral hepatitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the efficacy and safety of glutathione in the treatment of viral hepatitis.Methods:In the series,106 patients with viral hepatitis were randomly divided into groups A and B.Patients in group A received glutathione for four weeks,patient in group B received potassium magnesium aspartate for four weeks.Results:In Group A,at the end of treatment,the effective rate for tired and anorexia in patients with actue hepatitis were94.4% and 88.9%,respectively,in patients with chronic hepatitis were 88.7%,85.7%,which were significantly higher than that in group B(P0.05).STB,SCB,TBA,ALT and AST were lower in group A than in group B(P0.05).The increase of albumin after treatment was more significant in group A than in group B(P0.05).Conclusion:Glutathione has better efficacy than potassium magnesium aspartate in the treatment of patients with viral hepatitis.

Key concepts: Glutathione, Medicine, Internal medicine, Gastroenterology, Anorexia, Viral hepatitis, Group A, Group B

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of glutathione in the treatment of viral hepatitis — Research Paper | ScholarLens